Engineering ferroptosis radiosensitizer for SPARC-targeted degradation: A strategy to reverse radioresistant non-small cell lung cancer
{{output}}
Radioresistance poses a significant obstacle in the management of Non-Small Cell Lung Cancer (NSCLC), often diminishing the effectiveness of radiotherapy and leading to treatment failures and adverse clinical outcomes. This study develops radioresistant NSCLC ... ...
